Статті в журналах з теми "RNA therapeutic"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "RNA therapeutic".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Mahy, BWJ. "Therapeutic RNA?" Reviews in Medical Virology 15, no. 6 (2005): 349–50. http://dx.doi.org/10.1002/rmv.485.
Повний текст джерелаLiu, Xiang, Yu Zhang, Shurong Zhou, Lauren Dain, Lei Mei, and Guizhi Zhu. "Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines." Journal of Controlled Release 348 (August 2022): 84–94. http://dx.doi.org/10.1016/j.jconrel.2022.05.043.
Повний текст джерелаEVERTS, SARAH. "RNA DISTRACTION IS THERAPEUTIC." Chemical & Engineering News 87, no. 29 (July 20, 2009): 15. http://dx.doi.org/10.1021/cen-v087n029.p015a.
Повний текст джерелаPoller, Wolfgang, Juliane Tank, Carsten Skurk, and Martina Gast. "Cardiovascular RNA Interference Therapy." Circulation Research 113, no. 5 (August 16, 2013): 588–602. http://dx.doi.org/10.1161/circresaha.113.301056.
Повний текст джерела&NA;. "Therapeutic potential of RNA??interference." Inpharma Weekly &NA;, no. 1411 (November 2003): 2. http://dx.doi.org/10.2165/00128413-200314110-00001.
Повний текст джерелаStevenson, Mario. "Therapeutic Potential of RNA Interference." New England Journal of Medicine 351, no. 17 (October 21, 2004): 1772–77. http://dx.doi.org/10.1056/nejmra045004.
Повний текст джерелаHan, Xuexiang, Michael J. Mitchell, and Guangjun Nie. "Nanomaterials for Therapeutic RNA Delivery." Matter 3, no. 6 (December 2020): 1948–75. http://dx.doi.org/10.1016/j.matt.2020.09.020.
Повний текст джерелаSioud, Mouldy, and Marianne Leirdal. "Therapeutic RNA and DNA enzymes." Biochemical Pharmacology 60, no. 8 (October 2000): 1023–26. http://dx.doi.org/10.1016/s0006-2952(00)00395-6.
Повний текст джерелаNovina, C. D. "Therapeutic potential of RNA interference." Biomedicine & Pharmacotherapy 58, no. 4 (May 2004): 270. http://dx.doi.org/10.1016/j.biopha.2002.12.001.
Повний текст джерелаvan Ommen, Gert-Jan B., and Annemieke Aartsma-Rus. "Advances in therapeutic RNA-targeting." New Biotechnology 30, no. 3 (March 2013): 299–301. http://dx.doi.org/10.1016/j.nbt.2013.01.005.
Повний текст джерелаJana, S., C. Chakraborty, S. Nandi, and J. K. Deb. "RNA interference: potential therapeutic targets." Applied Microbiology and Biotechnology 65, no. 6 (September 15, 2004): 649–57. http://dx.doi.org/10.1007/s00253-004-1732-1.
Повний текст джерелаHastings, Michelle L., and Adrian R. Krainer. "RNA therapeutics." RNA 29, no. 4 (March 16, 2023): 393–95. http://dx.doi.org/10.1261/rna.079626.123.
Повний текст джерелаLi, Xinyi, Wenchen Pu, Song Chen, and Yong Peng. "Therapeutic targeting of RNA-binding protein by RNA-PROTAC." Molecular Therapy 29, no. 6 (June 2021): 1940–42. http://dx.doi.org/10.1016/j.ymthe.2021.04.032.
Повний текст джерелаAdachi, Hironori, Martin Hengesbach, Yi-Tao Yu, and Pedro Morais. "From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies." Biomedicines 9, no. 5 (May 14, 2021): 550. http://dx.doi.org/10.3390/biomedicines9050550.
Повний текст джерелаLundstrom, Kenneth. "Self-Replicating RNA Viruses for RNA Therapeutics." Molecules 23, no. 12 (December 13, 2018): 3310. http://dx.doi.org/10.3390/molecules23123310.
Повний текст джерелаDejong, Eric, Burkhard Luy, and John Marino. "RNA and RNA-Protein Complexes as Targets for Therapeutic Intervention." Current Topics in Medicinal Chemistry 2, no. 3 (March 1, 2002): 289–302. http://dx.doi.org/10.2174/1568026023394245.
Повний текст джерелаTafech, Alaeddin, Tyler Bassett, Dan Sparanese, and Chow Lee. "Destroying RNA as a Therapeutic Approach." Current Medicinal Chemistry 13, no. 8 (April 1, 2006): 863–81. http://dx.doi.org/10.2174/092986706776361021.
Повний текст джерелаGhosal, Anubrata, Ahmad Kabir, and Abul Mandal. "RNA interference and its therapeutic potential." Open Medicine 6, no. 2 (April 1, 2011): 137–47. http://dx.doi.org/10.2478/s11536-011-0005-5.
Повний текст джерелаGoyal, Bhoomika R., Mayur M. Patel, Mithil K. Soni, and Shraddha V. Bhadada. "Therapeutic opportunities of small interfering RNA." Fundamental & Clinical Pharmacology 23, no. 4 (August 2009): 367–86. http://dx.doi.org/10.1111/j.1472-8206.2009.00694.x.
Повний текст джерелаKrueger, Robert J. "Ribozymes: RNA as a Therapeutic Agent." American Pharmacy 35, no. 1 (January 1995): 12–13. http://dx.doi.org/10.1016/s0160-3450(16)33859-4.
Повний текст джерелаRead, Martin L., Mark Stevenson, Paul J. Farrow, Lee B. Barrett, and Leonard W. Seymour. "RNA-based therapeutic strategies for cancer." Expert Opinion on Therapeutic Patents 13, no. 5 (May 2003): 627–38. http://dx.doi.org/10.1517/13543776.13.5.627.
Повний текст джерелаStein, Richard A. "RNA Silencing Finds Its Therapeutic Voice." Genetic Engineering & Biotechnology News 40, no. 3 (March 1, 2020): 28–30. http://dx.doi.org/10.1089/gen.40.03.08.
Повний текст джерелаMintz, Paul, Vikash Reebye, Pål Sætrom, John J. Rossi, and Nagy A. Habib. "Exploiting RNA activation for therapeutic applications." Cell and Gene Therapy Insights 1, no. 1 (September 15, 2015): 14–18. http://dx.doi.org/10.18609/cgti.2015.003.
Повний текст джерелаSundaram, Padma, Helena Kurniawan, Mark E. Byrne, and Jacek Wower. "Therapeutic RNA aptamers in clinical trials." European Journal of Pharmaceutical Sciences 48, no. 1-2 (January 2013): 259–71. http://dx.doi.org/10.1016/j.ejps.2012.10.014.
Повний текст джерелаUprichard, Susan L. "The therapeutic potential of RNA interference." FEBS Letters 579, no. 26 (August 15, 2005): 5996–6007. http://dx.doi.org/10.1016/j.febslet.2005.08.004.
Повний текст джерелаKerr, Thomas A., and Nicholas O. Davidson. "Therapeutic RNA manipulation in liver disease." Hepatology 51, no. 3 (March 2010): 1055–61. http://dx.doi.org/10.1002/hep.23344.
Повний текст джерелаPiotrowska, Anna, Agnieszka Rybarczyk, Piotr Wierzbicki, Marzena Kotwas, Agata Wrońska, and Zbigniew Kmieć. "RNA interference – mechanism and therapeutic possibilities." Polish Annals of Medicine 16, no. 1 (March 15, 2023): 138–47. http://dx.doi.org/10.29089/paom/162206.
Повний текст джерелаBajan, Sarah, and Gyorgy Hutvagner. "RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs." Cells 9, no. 1 (January 7, 2020): 137. http://dx.doi.org/10.3390/cells9010137.
Повний текст джерелаFerdows, Bijan Emiliano, Dylan Neal Patel, Wei Chen, Xiangang Huang, Na Kong, and Wei Tao. "RNA cancer nanomedicine: nanotechnology-mediated RNA therapy." Nanoscale 14, no. 12 (2022): 4448–55. http://dx.doi.org/10.1039/d1nr06991h.
Повний текст джерелаPaluszczak, Jarosław. "Therapeutic targeting of alternative splicing." Farmacja Polska 75, no. 11 (December 29, 2019): 605–16. http://dx.doi.org/10.32383/farmpol/115754.
Повний текст джерелаAziz Ahmad, Kashif, Saleha Akram Nizami, and Muhammad Haroon Ghous. "Coronavirus - Drug Discovery and Therapeutic Drug Monitoring Options." Pharmaceutics and Pharmacology Research 5, no. 2 (January 6, 2022): 01–04. http://dx.doi.org/10.31579/2693-7247/044.
Повний текст джерелаChen, Genghao, Dhruva Katrekar, and Prashant Mali. "RNA-Guided Adenosine Deaminases: Advances and Challenges for Therapeutic RNA Editing." Biochemistry 58, no. 15 (April 3, 2019): 1947–57. http://dx.doi.org/10.1021/acs.biochem.9b00046.
Повний текст джерелаBennett, C. Frank, and Eric E. Swayze. "RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform." Annual Review of Pharmacology and Toxicology 50, no. 1 (February 2010): 259–93. http://dx.doi.org/10.1146/annurev.pharmtox.010909.105654.
Повний текст джерелаHaque, Sakib, Kiri Cook, Gaurav Sahay, and Conroy Sun. "RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer." Pharmaceutics 13, no. 10 (October 15, 2021): 1694. http://dx.doi.org/10.3390/pharmaceutics13101694.
Повний текст джерелаMalik, Amarila. "RNA THERAPEUTIC, PENDEKATAN BARU DALAM TERAPI GEN." Majalah Ilmu Kefarmasian 2, no. 2 (August 2005): 51–61. http://dx.doi.org/10.7454/psr.v2i2.3384.
Повний текст джерелаNeil, Christopher R., Michael W. Seiler, Dominic J. Reynolds, Jesse J. Smith, Frédéric H. Vaillancourt, Peter G. Smith, and Anant A. Agrawal. "Reprogramming RNA processing: an emerging therapeutic landscape." Trends in Pharmacological Sciences 43, no. 5 (May 2022): 437–54. http://dx.doi.org/10.1016/j.tips.2022.02.011.
Повний текст джерелаGao, Minsong, Qingyi Zhang, Xin-Hua Feng, and Jianzhao Liu. "Synthetic modified messenger RNA for therapeutic applications." Acta Biomaterialia 131 (September 2021): 1–15. http://dx.doi.org/10.1016/j.actbio.2021.06.020.
Повний текст джерелаZiemniak, Marcin, Malwina Strenkowska, Joanna Kowalska, and Jacek Jemielity. "Potential therapeutic applications of RNA cap analogs." Future Medicinal Chemistry 5, no. 10 (June 2013): 1141–72. http://dx.doi.org/10.4155/fmc.13.96.
Повний текст джерелаLi, Y., H. Wu, Y. Niu, Y. Hu, Q. Li, C. Cao, and J. Cai. "Development of RNA Aptamer-Based Therapeutic Agents." Current Medicinal Chemistry 20, no. 29 (August 1, 2013): 3655–63. http://dx.doi.org/10.2174/0929867311320290011.
Повний текст джерелаKim, Young Joon, and Omar Abdel-Wahab. "Therapeutic targeting of RNA splicing in myelodysplasia." Seminars in Hematology 54, no. 3 (July 2017): 167–73. http://dx.doi.org/10.1053/j.seminhematol.2017.06.007.
Повний текст джерелаCejka, Daniel, Doris Losert, and Volker Wacheck. "Short interfering RNA (siRNA): tool or therapeutic?" Clinical Science 110, no. 1 (December 12, 2005): 47–58. http://dx.doi.org/10.1042/cs20050162.
Повний текст джерелаThiel, Kristina W., and Paloma H. Giangrande. "Therapeutic Applications of DNA and RNA Aptamers." Oligonucleotides 19, no. 3 (September 2009): 209–22. http://dx.doi.org/10.1089/oli.2009.0199.
Повний текст джерелаEgli, Martin, and Muthiah Manoharan. "Re-Engineering RNA Molecules into Therapeutic Agents." Accounts of Chemical Research 52, no. 4 (March 26, 2019): 1036–47. http://dx.doi.org/10.1021/acs.accounts.8b00650.
Повний текст джерелаROSSI, J., and N. SARVER. "RNA enzymes (ribozymes) as antiviral therapeutic agents." Trends in Biotechnology 8 (1990): 179–83. http://dx.doi.org/10.1016/0167-7799(90)90169-x.
Повний текст джерелаTakeshita, Fumitaka, and Takahiro Ochiya. "Therapeutic potential of RNA interference against cancer." Cancer Science 97, no. 8 (August 2006): 689–96. http://dx.doi.org/10.1111/j.1349-7006.2006.00234.x.
Повний текст джерелаMirón-Barroso, Sofía, Joana S. Correia, Adam E. Frampton, Mark P. Lythgoe, James Clark, Laura Tookman, Silvia Ottaviani, et al. "Polymeric Carriers for Delivery of RNA Cancer Therapeutics." Non-Coding RNA 8, no. 4 (August 2, 2022): 58. http://dx.doi.org/10.3390/ncrna8040058.
Повний текст джерелаVeedu, Rakesh N., and Jesper Wengel. "Locked nucleic acid as a novel class of therapeutic agents." RNA Biology 6, no. 3 (July 2009): 321–23. http://dx.doi.org/10.4161/rna.6.3.8807.
Повний текст джерелаAigner, Achim. "Transkingdom RNA interference (tkRNAi) as a new delivery tool for therapeutic RNA." Expert Opinion on Biological Therapy 9, no. 12 (September 22, 2009): 1533–42. http://dx.doi.org/10.1517/14712590903307354.
Повний текст джерелаWang, Yanyan, Varada Anirudhan, Ruikun Du, Qinghua Cui, and Lijun Rong. "RNA‐dependent RNA polymerase of SARS‐CoV‐2 as a therapeutic target." Journal of Medical Virology 93, no. 1 (July 19, 2020): 300–310. http://dx.doi.org/10.1002/jmv.26264.
Повний текст джерелаAartsma-Rus, Annemieke. "Antisense-mediated modulation of splicing: Therapeutic implications for Duchenne muscular dystrophy." RNA Biology 7, no. 4 (July 2010): 453–61. http://dx.doi.org/10.4161/rna.7.4.12264.
Повний текст джерела